UPDATE 2-U.S. judge in Texas invalidates Allergan patents on Restasis
October 16, 2017 at 14:12 PM EDT
Oct 16 (Reuters) - A U.S. judge invalidated patents on Allergan Plc's dry eye medicine Restasis on the grounds that the patents cover obvious ideas, a decision that drove the pharmaceutical company's shares down more than 6 percent.
